A multilocus genotyping assay for cardiovascular disease

被引:48
作者
Cheng, S
Pallaud, C
Grow, MA
Scharf, SJ
Erlich, HA
Klitz, W
Pullinger, CR
Malloy, MJ
Kane, JP
Siest, G
Visvikis, S
机构
[1] Roche Mol Syst Inc, Dept Human Genet, Alameda, CA 94501 USA
[2] Ctr Med Prevent, Nancy, France
[3] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
[4] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
关键词
cardiovascular disease; multilocus genotyping; oligonucleotide array; polymerase chain reaction;
D O I
10.1515/CCLM.1998.096
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In our efforts to develop diagnostic tests for complex multifactorial disorders, and to assist the research community in evaluating genetic markers for predisposition to cardiovascular disease, we have developed a prototype assay to genotype up to 35 variable sites among 15 genes. The candidate markers in this panel were selected from biological pathways likely to contribute to the development and progression of cardiovascular disease. Each sample is amplified in two multiplex polymerase chain reactions that are then hybridized to an array of immobilized oligonucleotide probes. The assay has been applied to a population-based cohort representing 238 families; allele frequencies observed among 455 unrelated parents from this cohort agree with available literature values. Data from a cohort of 142 lipid-clinic patients were used to explore locus associations with arterial occlusion, as measured by quantitative angiography. This prototype assay provides a research tool for studies to assess the association of multiple markers with disease, and for clinical studies to evaluate marker association with patient responsiveness to experimental therapies.
引用
收藏
页码:561 / 566
页数:6
相关论文
共 50 条
[1]  
[Anonymous], [No title captured]
[2]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[3]   ANGIOTENSIN-II TYPE-1 RECEPTOR GENE POLYMORPHISMS IN HUMAN ESSENTIAL-HYPERTENSION [J].
BONNARDEAUX, A ;
DAVIES, E ;
JEUNEMAITRE, X ;
FERY, I ;
CHARRU, A ;
CLAUSER, E ;
TIRET, L ;
CAMBIEN, F ;
CORVOL, P ;
SOUBRIER, F .
HYPERTENSION, 1994, 24 (01) :63-69
[4]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[5]   Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease [J].
Christensen, B ;
Frosst, P ;
LussierCacan, S ;
Selhub, J ;
Goyette, P ;
Rosenblatt, DS ;
Genest, J ;
Rozen, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) :569-573
[6]   AN APOLIPOPROTEIN CIII HAPLOTYPE PROTECTIVE AGAINST HYPERTRIGLYCERIDEMIA IS SPECIFIED BY PROMOTER AND 3' UNTRANSLATED REGION POLYMORPHISMS [J].
DAMMERMAN, M ;
SANDKUIJL, LA ;
HALAAS, JL ;
CHUNG, W ;
BRESLOW, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4562-4566
[7]  
Dawber T. R., 1980, THE FRAMINGHAM STUDY
[8]   GENETIC-HETEROGENEITY OF APOLIPOPROTEIN-E AND ITS INFLUENCE ON PLASMA-LIPID AND LIPOPROTEIN LEVELS [J].
DEKNIJFF, P ;
VANDENMAAGDENBERG, AMJM ;
FRANTS, RR ;
HAVEKES, LM .
HUMAN MUTATION, 1994, 4 (03) :178-194
[9]   Ethnic variation and in vivo effects of the -93t->g promoter variant in the lipoprotein lipase gene [J].
Ehrenborg, E ;
Clee, SM ;
Pimstone, SN ;
Reymer, PWA ;
Benlian, P ;
Hoogendijk, CF ;
Davis, HJ ;
Bissada, N ;
Miao, L ;
Gagne, SE ;
Greenberg, LJ ;
Henry, R ;
Henderson, H ;
Ordovas, JM ;
Schaefer, EJ ;
Kastelein, JJP ;
Kotze, MJ ;
Hayden, MR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2672-2678
[10]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113